Dr. Craig Gordon Launches Alternative Investment Firm GordonMD Global Investments

Previously Dr. Gordon managed a portfolio of on average over $7 billion, and helped oversee additional portfolios totaling billions more.

BEVERLY HILLS, CA--(BUSINESS WIRE)--Today Craig Gordon, MD, a licensed physician with over a decade of buy-side experience managing global biopharmaceutical portfolios, proudly announces the launch of GordonMD Global Investments. The firm is focused on investments in private and publicly traded global growth and innovative biopharma companies primarily located in the U.S., Japan, and Europe.

GordonMD Global Investments stands apart from other equity managers, including those focused on biopharmaceutical or similar sector and industries. The firm’s perspective is derived from Dr. Gordon’s medical knowledge and training combined with his over 10 years of experience at The Capital Group, where he served as an Equity Investment Analyst, built and managed an on average over $7 billion AUM portfolio across various mandates, and assisted with oversight of additional multi-billion dollar AUM portfolios.

“The launch of GordonMD Global Investments is the culmination of my decades of experience as a portfolio manager, investment analyst and physician. At GordonMD Global Investments we employ my proprietary analysis to target truly innovative companies with best-in-class assets that move clinically with the potential not only to change the standard of care but also to generate outsized returns. The firm combines my medical and investing acumen to create a singular advantage for institutional and accredited high-net worth investors,” said Craig Gordon, MD, Founder, CEO, and CIO of GordonMD Global Investments.

Prior to establishing his own firm, Dr. Gordon worked at The Capital Group for 10+ years, where he was an Equity Investment Analyst and built his own portfolio and established a successful track record in Private Placements and with multiple fund mandates, including U.S. Growth, Global Growth and Small Cap. Prior to The Capital Group, he worked for the Cowen Group in New York as a Biotechnology Equity Research Analyst and Associate. Dr. Gordon lives and works in Los Angeles but frequently visits management teams and attends conferences across the world. He earned an MBA from Duke University, a Doctor of Medicine from the University of Miami Miller School of Medicine, and a B.A. in Economics from Cornell University.

The firm’s service providers include Jefferies, Bank of America, SS&C, Seward & Kissel LLP, Constellation Consulting Services LLC, and Goldman Sachs.

THIS PRESS RELEASE IS INTENDED FOR INFORMATIONAL PURPOSES ONLY. THIS IS NOT AN OFFER OR SOLICITATION WITH RESPECT TO THE PURCHASE OR SALE OF ANY FUND OR SECURITY.

Media Contact: Mitch Ackles, 646-657-9230, mitch@hedgefundpr.net
Investor Relations Contact: ir@gordonmdglobalinv.com